ICN acquires Siemens' dosimetry service:
This article was originally published in Clinica
Executive Summary
ICN Pharmaceuticals has acquired Siemens' dosimetry service business division for an undisclosed amount, following US regulatory clearance. ICN says the purchase will allow it to expand its radiation detection service from the US into international markets. The dosimetry service, which is part of Siemens Medical Systems, had worldwide revenues of $9.3 million in fiscal 1995. Global sales for dosimetry services were around $200 million in 1994.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.